Differentiation induced by Achyrocline satureioides (Lam) infusion in PC12 cells
暂无分享,去创建一个
F. Dajas | F. Arredondo | C. Echeverry | A. Morquio | M. Blasina | M. F. Blasina | L. Vaamonde | Andrea Morquio
[1] Sonia Ramos,et al. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. , 2007, The Journal of nutritional biochemistry.
[2] K. Németh,et al. Food Content, Processing, Absorption and Metabolism of Onion Flavonoids , 2007, Critical reviews in food science and nutrition.
[3] P. Lazarovici,et al. Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development. , 2006, Current pharmaceutical design.
[4] Hong-Zhuan Chen,et al. Panaxynol induces neurite outgrowth in PC12D cells via cAMP- and MAP kinase-dependent mechanisms. , 2006, Chemico-biological interactions.
[5] Hui-min Yu,et al. Protection of oxidative preconditioning against apoptosis induced by H2O2 in PC12 cells: Mechanisms via MMP, ROS, and Bcl-2 , 2005, Brain Research.
[6] R. Levine,et al. Neuroprotection by NGF in the PC12 in vitro OGD model: involvement of mitogen-activated protein kinases and gene expression. , 2005 .
[7] M. Corasaniti,et al. From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens. , 2005, Pharmacological research.
[8] R. Levine,et al. Neuroprotection by NGF in the PC12 In Vitro OGD Model , 2005, Annals of the New York Academy of Sciences.
[9] Xu-xu Zheng,et al. Nardostachys chinensis glycoside induces characteristics of neuronal differentiation in rat pheochromocytoma PC12 cells. , 2005, Biological & pharmaceutical bulletin.
[10] C. Behl. Oxidative stress in Alzheimer's disease: implications for prevention and therapy. , 2005, Sub-cellular biochemistry.
[11] P. Maher,et al. Induction of PC12 cell differentiation by flavonoids is dependent upon extracellular signal‐regulated kinase activation , 2004, Journal of neurochemistry.
[12] M. Andrades,et al. Antioxidant, a pro-oxidant and cytotoxic effects of Achyrocline satureioides extracts. , 2004, Life sciences.
[13] Y. Surh,et al. Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies. , 2004, Toxicology letters.
[14] C. Rice-Evans,et al. Flavonoids: antioxidants or signalling molecules? , 2004, Free radical biology & medicine.
[15] F. Blasina,et al. Cytoprotection by Achyrocline satureioides (Lam) D.C. and some of its main flavonoids against oxidative stress. , 2004, Journal of ethnopharmacology.
[16] F. Blasina,et al. Neuroprotection by flavonoids. , 2003, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[17] T Seal,et al. Screening of antioxidant activity of three Indian medicinal plants, traditionally used for the management of neurodegenerative diseases. , 2003, Journal of ethnopharmacology.
[18] E. Schapoval,et al. LC determination of flavonoids: separation of quercetin, luteolin and 3-O-methylquercetin in Achyrocline satureioides preparations. , 2002, Journal of pharmaceutical and biomedical analysis.
[19] C. Culmsee,et al. p75 neurotrophin receptor is required for constitutive and NGF‐induced survival signalling in PC12 cells and rat hippocampal neurones , 2002, Journal of neurochemistry.
[20] C. Rice-Evans,et al. Dietary Flavonoids as Potential Neuroprotectants , 2002, Biological chemistry.
[21] R. Williamson,et al. Achyrofuran, a new antihyperglycemic dibenzofuran from the South American medicinal plant Achyrocline satureioides. , 2002, Journal of natural products.
[22] E. Middleton,et al. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. , 2000, Pharmacological reviews.
[23] P. Gluckman,et al. Neuroprotective strategies for basal ganglia degeneration: Parkinson’s and Huntington’s diseases , 2000, Progress in Neurobiology.
[24] H. Shinmoto,et al. Structure-activity relationships of flavonoids and the induction of granulocytic- or monocytic-differentiation in HL60 human myeloid leukemia cells. , 1998, Bioscience, biotechnology, and biochemistry.
[25] A. Hofman,et al. Dietary antioxidants and Parkinson disease. The Rotterdam Study. , 1997, Archives of neurology.
[26] D. Commenges,et al. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. , 1997, Revue neurologique.
[27] J. Perez-polo,et al. Effects of Nerve Growth Factor on Glutathione Peroxidase and Catalase in PC 12 Cells , 1994, Journal of neurochemistry.
[28] P. Pechan,et al. Effect of nerve growth factor on lesioneo PC12 cells , 1991 .
[29] L. Golbe,et al. Case-control study of early life dietary factors in Parkinson's disease. , 1988, Archives of neurology.
[30] E. Schenkel,et al. Pharmacological investigations on Achyrocline satureioides (LAM.) DC., Compositae. , 1988, Journal of ethnopharmacology.
[31] E. Wollenweber. Occurrence of flavonoid aglycones in medicinal plants. , 1988, Progress in clinical and biological research.
[32] F. Denizot,et al. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. , 1986, Journal of immunological methods.
[33] L. Greene,et al. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[34] V. L. Singleton,et al. Colorimetry of Total Phenolics with Phosphomolybdic-Phosphotungstic Acid Reagents , 1965, American Journal of Enology and Viticulture.